SCHEMBL23972171

SCHEMBL23972171

c1ccc(-c2cccc(-c3cc(-c4ccccc4)nc(-n4c5ccccc5c5cc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)ccc54)n3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
ATM Q13315 1/20 0.45
PTGER4 P35408 1/20 0.37
TSPO P30536 1/20 0.36
MAPT P10636 4/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
LMNA P02545 2/20 0.35
GLA P06280 1/20 0.35
MAPK1 P28482 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
HTT P42858 1/20 0.35
PTGES O14684 1/20 0.35
DHODH Q02127 1/20 0.35
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15626409 1.00 KDM4E (0.45) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL15748511 0.99 L3MBTL1 (0.46) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL15748614 0.97 L3MBTL1 (0.47) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL22751030 0.96 KDM4E (0.42) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL19845296 0.96 L3MBTL1 (0.44) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL17904190 0.96 L3MBTL1 (0.44) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL19845306 0.96 L3MBTL1 (0.44) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL19845330 0.96 L3MBTL1 (0.44) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL18213908 0.96 L3MBTL1 (0.44) KDM4EL3MBTL1ATMPTGER4TSPO
SCHEMBL19845341 0.96 L3MBTL1 (0.44) KDM4EL3MBTL1ATMPTGER4TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12041845-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2024-07-16 US disclosed
US-12041845-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2024-07-16 US disclosed
US-20210343949-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2021-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12041845-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same L1CAM, OR10J3, EPCAM KDM4E 2182/4885L3MBTL1 1380/4885ATM 2715/4885
US-20210343949-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME L1CAM, OR10J3, EPCAM KDM4E 2182/4885L3MBTL1 1380/4885ATM 2715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.